13.39 USD
↗ 0.01 (0.07%)PRE MARKET (AS OF 07:57 AM EDT)
Evommune, Inc. (EVMN) trades at $13.39 per share. Technical indicators currently signal "Sell". Key drivers include negative Return on Equity and a bearish Death Cross on the long-term moving averages. EVMN is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Aug 6, 2026.
Open?$13.37
High?$13.39
Low?$13.24
Prev. Close?$13.38
Volume?2.1K
Avg. Volume?1.2M
VWAP?$13.31
Rel. Volume?0.00x
Bid / Ask
Bid?$13.00 × 100
Ask?$13.49 × 900
Spread?$0.49
Midpoint?$13.25
Valuation & Ratios
Market Cap?481.9M
Shares Out?36.0M
Float?23.1M
Float %?64.2%
P/E Ratio?N/A
P/B Ratio?1.58
EPS?-$2.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Employees
48
Market Cap
469.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-11-06
Address
1891 PAGE MILL RD
PALO ALTO, CA
Phone: (650) 223-7745
PALO ALTO, CA
Phone: (650) 223-7745
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?17.36%High
Short Interest?4.0M
Days to Cover?3.7
Free Float23.1M
Avg Daily Volume1.1M
Settlement Date2026-07-15
Financial Health
Current Ratio?20.36Strong
Quick Ratio?20.36Strong
Cash Ratio?4.56Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.58CHEAP▾
Peers100
S&P85
P/S?37.07HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-5.4CHEAP▾
S&P97
EV/Sales?33.40HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-25.3%WEAK▾
S&P7
ROA?-23.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$434.1M
Fundamentals ratios updated end of day